"We are in the last phase of evaluation on what price we need to charge for oral incretin in India. By September we will have complete picture," said Vikrant Shrotriya, Corporate Vice-President and Managing Director of Novo Nordisk India in an interview to Moneycontrol.How to protect and exponentially Grow your investment portfolio during economic boom or bust, How learn stock market, How to earn money in stock market,earn money from home .
Novo Nordisk to launch two medications for diabetes, weight loss in 2022
"We are in the last phase of evaluation on what price we need to charge for oral incretin in India. By September we will have complete picture," said Vikrant Shrotriya, Corporate Vice-President and Managing Director of Novo Nordisk India in an interview to Moneycontrol.
Subscribe to:
Post Comments (Atom)
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Thirteen tier 2 and 3 cities register higher traffic in December than pre-COVID-19 levels.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment